Skip to content

Tropisetron, systemic inflammatory response syndrome, and off-pump coronary artery bypass grafting surgery

Tropisetron for alleviating systemic inflammatory response syndrome after off-pump coronary artery bypass grafting surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016927
Enrollment
Unknown
Registered
2018-07-03
Start date
2018-07-09
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic inflammatory response syndrome

Interventions

1:Tropisetron

Sponsors

Department of Anesthesiology, Beijing Chao-Yang Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients scheduled for elective off-pump coronary artery bypass grafting surgery; 18yr<Age<65yr; male; informed consent

Exclusion criteria

Exclusion criteria: Patients-related factors: recent myocardial infarction within 30 days; unstable angina with elevated CK-MB or cTnI; previous cardiac surgery; abnormal renal function; abnormal liver function; left ventricular ejection fraction of =35%; previous stroke. Perioperative factors: currently or recently taking immunosuppressive agents; use of radiocontrast agents within 7 days before surgery; preoperative white blood cell count 10 x10^9/L; emergency operations; planned simultaneous surgery; a second cardiac surgery during the same hospital stay; intraoperative use of cardiopulmonary bypass (CPB); discontinuation of postoperative tropisetron infusion; receive systemic steroids in the perioperative period; perioperative use of intra-aortic balloon pump (IABP); perioperative infection; surgical site infection.

Design outcomes

Primary

MeasureTime frame
Serum interleukin-8;Serum interleukin-6;White blood cell count;

Secondary

MeasureTime frame
Maximal percentage of serum creatinine increase compared to baseline;Serum Cardiac Troponin-I (cTnI);Serum CK-MB;Urinary Kidney Injury Molecule-1 (KIM-1);

Countries

China

Contacts

Public ContactChao Xiong

Beijing Chao-Yang hospital

xiongchao@ccmu.edu.cn+86 15810707287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026